Differential Sensitivity of Distinct Chlamydia trachomatis Isolates to IFN-γ-Mediated Inhibition

Resistance to the mouse pneumonitis (MoPn) strain of Chlamydia trachomatis has been mapped to MHC class II-restricted, IL-12-dependent CD4+ T cells that secrete a type 1 profile of proinflammatory cytokines, which includes IFN-γ and TNF-α. The relative contribution of IFN-γ is controversial, however, due to variation in results presented by different laboratories. To determine whether C. trachomatis strain differences contributed to this apparent conflict, the relative resistance of IFN-γ-deficient mice to murine and human strains of C. trachomatis was compared. All human serovars were much more sensitive to the direct inhibitory actions of IFN-γ than the MoPn strain. Furthermore, genital clearance of human serovar D in the C57BL/6 mouse was mediated by class II-independent mechanisms that probably involved local production of IFN-γ by cells of the innate immune system. TNF-α also contributed indirectly to host resistance against all strains tested. The differential susceptibility of distinct C. trachomatis strains to effector cytokines such as IFN-γ could not have been predicted by interstrain biologic variation or by the profile of cytokines stimulated during infection. These findings indicate that strain variation should be considered in situations where related isolates of a given parasite produce conflicting data in models of infection and immunity. They also suggest that stimulation of mucosal IFN-γ activity is a relevant goal for a human chlamydial vaccine.

[1]  M. Ward,et al.  B‐cell‐deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis , 1997, Immunology.

[2]  G. Kaplan,et al.  Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro , 1997, Infection and immunity.

[3]  K. Kelly,et al.  Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis , 1997, Infection and immunity.

[4]  G. Byrne,et al.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice , 1997, Infection and immunity.

[5]  H. Caldwell,et al.  Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice , 1997, Infection and immunity.

[6]  T. Otani,et al.  Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria , 1997, Infection and immunity.

[7]  H. Caldwell,et al.  Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. , 1997, Journal of immunology.

[8]  A. Andersen,et al.  The ribosomal intergenic spacer and domain I of the 23S rRNA gene are phylogenetic markers for Chlamydia spp. , 1997, International journal of systematic bacteriology.

[9]  M. Ward,et al.  Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response , 1997, Infection and immunity.

[10]  X. Li,et al.  Expression of functional ICAM-1 and VCAM-1 adhesion molecules by an immortalized epithelial cell clone derived from the small intestine. , 1997, Cellular immunology.

[11]  D. Conway,et al.  T helper type‐1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring , 1996, Clinical and experimental immunology.

[12]  S. West,et al.  Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma , 1996, Infection and immunity.

[13]  A. Sher,et al.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.

[14]  J. Igietseme,et al.  Molecular mechanism of T‐cell control of Chlamydia in mice: role of nitric oxide in vivo , 1996, Immunology.

[15]  D. Radzioch,et al.  In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice , 1996, Infection and immunity.

[16]  R. Morrison,et al.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection , 1995, Infection and immunity.

[17]  H. Caldwell,et al.  Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection , 1995, Infection and immunity.

[18]  H. Caldwell,et al.  CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract , 1995, Infection and immunity.

[19]  R. Rank,et al.  Role of CD8 T cells in primary Chlamydia infection , 1995, Infection and immunity.

[20]  K. Tanaka,et al.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[21]  M. Starnbach,et al.  Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. , 1994, Journal of immunology.

[22]  I. Schneider,et al.  Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells , 1994, The Journal of experimental medicine.

[23]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[24]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[25]  D. Magee,et al.  Gamma interferon levels during Chlamydia trachomatis pneumonia in mice , 1993, Infection and immunity.

[26]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[27]  M. Woods,et al.  Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells , 1993, Infection and immunity.

[28]  E. Unanue,et al.  Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. , 1993, Journal of immunology.

[29]  R. Rank,et al.  Effect of gamma interferon on resolution of murine chlamydial genital infection , 1992, Infection and immunity.

[30]  K. Erlich,et al.  Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis , 1991, Infection and immunity.

[31]  M. Meltzer,et al.  Cytokine‐Induced Synthesis of Nitrogen Oxides in Macrophages: A Protective Host Response to Leishmania and Other Intracellular Pathogens , 1991, Journal of leukocyte biology.

[32]  L. Bonewald,et al.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis , 1990, Infection and immunity.

[33]  E. Borden,et al.  Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. , 1989, Journal of interferon research.

[34]  D. Williams,et al.  Characterization of gamma interferon-mediated cytotoxicity to chlamydia-infected fibroblasts , 1989, Infection and immunity.

[35]  D. Williams,et al.  Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice , 1988, Infection and immunity.

[36]  D. Wallach,et al.  Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor , 1988, Infection and immunity.

[37]  R. Rank,et al.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection , 1988, Infection and immunity.

[38]  E. Peterson,et al.  Ultrastructural analysis of the anti-chlamydial activity of recombinant murine interferon-gamma. , 1987, Experimental and molecular pathology.

[39]  S. Halbert,et al.  Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. , 1987, The Journal of infectious diseases.

[40]  E. Borden,et al.  Induction of Tryptophan Degradation In Vitro and In Vivo: A γ-Interferon-Stimulated Activity , 1986 .

[41]  G. Byrne,et al.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells , 1986, Infection and immunity.

[42]  E. Peterson,et al.  The anti-chlamydial and anti-proliferative activities of recombinant murine interferon-gamma are not dependent on tryptophan concentrations. , 1985, Journal of immunology.

[43]  D. Williams,et al.  Cellular immunity to the mouse pneumonitis agent. , 1984, The Journal of infectious diseases.

[44]  G. Byrne,et al.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin , 1983, Infection and immunity.

[45]  H. Caldwell,et al.  Immunoassay for detecting Chlamydia trachomatis major outer membrane protein , 1983, Journal of clinical microbiology.

[46]  A. Sher,et al.  Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis. , 1983, Journal of immunology.

[47]  H. Murray,et al.  Lymphokine enhances oxygen-independent activity against intracellular pathogens , 1983, The Journal of experimental medicine.

[48]  C. Pavia,et al.  Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells , 1983, Infection and immunity.

[49]  E. A. Havell,et al.  Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells) , 1983, Infection and immunity.

[50]  H. Caldwell,et al.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis , 1981, Infection and immunity.

[51]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[52]  J. Schachter Pathogenesis of chlamydial infections. , 1989, Pathology and immunopathology research.